Clarivate PLC (CLVT) News
Filter CLVT News Items
CLVT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CLVT News Highlights
- CLVT's 30 day story count now stands at 2.
- Over the past 14 days, the trend for CLVT's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DRUG are the most mentioned tickers in articles about CLVT.
Latest CLVT News From Around the Web
Below are the latest news stories about CLARIVATE PLC that investors may wish to consider to help them evaluate CLVT as an investment opportunity.
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment ParadigmClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of a new special report series, Electrophysiology Mapping and Ablation Devices Market Insights. The Clarivate MedTech Insights reports reveal new forecast predictions for the ablation catheter market in four geographies: the US, Europe, Japan and Asia Pacific. Findings show pulsed-field ablation (PFA) is poised to revolutionize the |
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug DevelopmentClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more. |
Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 ListClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. |
Clarivate to Present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that Jonathan Gear, Chief Executive Officer, will present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on Tuesday, November 14, 2023 at 1:20 pm Eastern Time. |
Clarivate Reports Third Quarter 2023 ResultsClarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today reported results for the third quarter. |
Clarivate Report Reveals China Challenging U.S. Research Dominance, Signaling Future Research AmbitionsClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released a report from the Institute for Scientific Information (ISI)™ which reveals that China's* research economy has seen a dramatic increase in quality and its research is increasingly valued beyond its borders. China is also diversifying beyond its traditional strengths in technology and physical sciences to focus on new areas such as biomolecular |
Clarivate Partners with EveryLibrary to Support and Nurture Libraries in the U.S.Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced a partnership with EveryLibrary, the non-partisan advocacy organization for libraries. |
BioWorld by Clarivate Examines Impact of Emerging Medicines on ObesityBioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, examines the impact of emerging obesity medicines in a new three-part series, The Rise of Obesity. The special coverage offers in-depth analysis of how the anticipated multibillion-dollar market potential for obesity medications in the coming years will impact biopharma, insurance companies and a patient population in need of safer opti |
Will Clarivate PLC (CLVT) Beat Estimates Again in Its Next Earnings Report?Clarivate PLC (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
Clarivate Renews Partnership with The Federal Library and Information NetworkClarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the renewal of its contract with the Federal Library and Information Network (FEDLINK). This contract is in addition to the contract agreed with ProQuest, part of Clarivate™. Together these commitments will equip government libraries and information centers with premier workflow management tools and cutting-edge research and discovery solutio |